Neil W Gibson

CIK 1555918 · Chief Scientific Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

36

Lifetime Open-Market Net

-$2.42M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
STTK Director $4.94 $0 7 2026-06-02
TIL Director $7.92 $0 5 2025-05-29
TCR2 THERAPEUTICS INC. (TCRR) Delisted Director 493,791 $1.48 $730.8K -$525.2K 8 2023-06-01
Regulus Therapeutics Inc. (RGLS) Delisted Chief Scientific Officer 8,655 $8.16 $70.6K -$1.90M 16 2015-01-30

Recent Filings · Page 4 of 4

36 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-01-23 Regulus Therapeutics Inc. (RGLS) Delisted Mixed -$24.0K EDGAR
2014-01-21 Regulus Therapeutics Inc. (RGLS) Delisted Mixed -$26.8K EDGAR
2014-01-17 Regulus Therapeutics Inc. (RGLS) Delisted Mixed -$6.9K EDGAR
2013-12-16 Regulus Therapeutics Inc. (RGLS) Delisted Grant (A) $0 EDGAR
2013-02-14 Regulus Therapeutics Inc. (RGLS) Delisted Exer (M) +50,000 $87.0K EDGAR
2012-12-13 Regulus Therapeutics Inc. (RGLS) Delisted Grant (A) $0 EDGAR
Showing 3136 of 36
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.